Methods to measure biophysical attributes of the posterior eye
Glaucoma and myopia are significant causes of vision loss worldwide, affecting millions of people and imposing a substantial socioeconomical burden. Effective vision care strategies are urgently needed to reduce blindness caused by these conditions and mitigate their associated risks. In vivo imaging of the posterior eye, specifically the sclera and optic nerve, is crucial for evaluating a person's risk for glaucoma progression or developing high myopia. However, current imaging methods lack the ability to accurately measure the biophysical attributes of the posterior eye in real-time, presenting a critical need for a more effective and non-invasive imaging technology.
Our cutting-edge technology offers an advanced in vivo imaging method to precisely measure the biophysical attributes of the posterior eye, including the sclera and optic nerve. Leveraging optical coherence tomography (OCT) and computational modeling, our method provides detailed insights into the posterior sclera's stiffness, thickness, and radius, allowing for a comprehensive assessment of a person's risk for glaucoma and myopia-related complications. Additionally, our technology captures essential parameters such as optic nerve diameter and spatial distribution of mechanical deformation in response to the ocular pulse, enabling early detection and evaluation of glaucoma risk.